Thats why we offer a comprehensive menu of cutting-edge treatments
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Karagiannis T., Tsapas A., Athanasiadou E., Avgerinos I., Liakos A., Matthews D.R., Bekiari E
Even if the COM patent is challenged and invalidated on day one of approval, NCE exclusivity provides five years of protection
Most patients experience mild to moderate nausea, constipation, or vomiting in the opening days of treatment, yet these reactions usually decline as your system adjusts over several weeks
References: Hallare J, Gerriets V
Skin side effects and other adverse events must be reported through the clinical trial sponsor's pharmacovigilance processes, with MHRA oversight ensuring patient safety during the investigational phase